D.E. Shaw & Co
NKGNW

D.E. Shaw & Co’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

D.E. Shaw & Co’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$5K – 4859
2024
Q4 		$5K Hold
50,000
– – ﹤0.01% 4303
2024
Q3 		$3.54K Hold
50,000
– – ﹤0.01% 4441
2024
Q2 		$4.95K Hold
50,000
– – ﹤0.01% 4364
2024
Q1 		$8K Hold
50,000
– – ﹤0.01% 4190
2023
Q4 		$3.54K Hold
50,000
– – ﹤0.01% 4202
2023
Q3 		$19.7K Hold
50,000
– – ﹤0.01% 3988
2023
Q2 		$10K Hold
50,000
– – ﹤0.01% 4049
2023
Q1 		$7K Hold
50,000
– – ﹤0.01% 4282
2022
Q4 		$4.25K Hold
50,000
– – ﹤0.01% 4700
2022
Q3 		$8K Hold
50,000
– – ﹤0.01% 4963
2022
Q2 		$13K Hold
50,000
– – ﹤0.01% 5095
2022
Q1 		$30K Hold
50,000
– – ﹤0.01% 5272
2021
Q4 		$58K Hold
50,000
– – ﹤0.01% 5177
2021
Q3 		$58K Buy
+50,000
New +$62.5K ﹤0.01% 4801

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

D.E. Shaw & Co's NKGNW Position: Q1 2025 in Review

D.E. Shaw & Co sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 50,000 shares — an estimated $5K sold.

D.E. Shaw & Co first reported a position in NKGNW in Q3 2021 and held it in 14 quarters. The position peaked at $58K in Q4 2021. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

  • D.E. Shaw & Co reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 50,000 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $5K.
  • D.E. Shaw & Co first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 14 quarters.
  • D.E. Shaw & Co's NKGen Biotech, Inc. Warrants position peaked at $58K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.